Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells

Background:Tumour-initiating cells (TICs) or cancer stem cells can exist as a small population in malignant tissues. The signalling pathways activated in TICs that contribute to tumourigenesis are not fully understood.Methods:Several breast cancer cell lines were sorted with CD24 and CD44, known markers for enrichment of breast cancer TICs. Tumourigenesis was analysed using sorted cells and total RNA was subjected to gene expression profiling and gene set enrichment analysis (GSEA).Results:We showed that several breast cancer cell lines have a small population of CD24−/low/CD44+ cells in which TICs may be enriched, and confirmed the properties of TICs in a xenograft model. GSEA revealed that CD24−/low/CD44+ cell populations are enriched for genes involved in transforming growth factor-β, tumour necrosis factor, and interferon response pathways. Moreover, we found the presence of nuclear factor-κB (NF-κB) activity in CD24−/low/CD44+ cells, which was previously unrecognised. In addition, NF-κB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) prevented tumourigenesis of CD24−/low/CD44+ cells in vivo.Conclusion:Our findings suggest that signalling pathways identified using GSEA help to identify molecular targets and biomarkers for TIC-like cells.

[1]  J. Massagué,et al.  TGFβ in Cancer , 2008, Cell.

[2]  Sung-Hwan Park,et al.  Toll-like receptor 2 ligand mediates the upregulation of angiogenic factor, vascular endothelial growth factor and interleukin-8/CXCL8 in human rheumatoid synovial fibroblasts. , 2007, Immunology letters.

[3]  Michael Karin,et al.  NF-kappaB in cancer: from innocent bystander to major culprit. , 2002, Nature reviews. Cancer.

[4]  K. Cornetta,et al.  Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods , 2002, Gene Therapy.

[5]  Hiroyuki Aburatani,et al.  Identification of Toll-Like Receptor 3 as a Potential Therapeutic Target in Clear Cell Renal Cell Carcinoma , 2007, Clinical Cancer Research.

[6]  A. Griffioen,et al.  NF-κB: a new player in angiostatic therapy , 2008, Angiogenesis.

[7]  T. Shono,et al.  Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis , 1997, Molecular and cellular biology.

[8]  Irving L Weissman,et al.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.

[9]  A. Fauci,et al.  Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. , 1997, Journal of immunology.

[10]  K. Umezawa.  Inhibition of tumor growth by NF-kappaB inhibitors. , 2006, Cancer science.

[11]  G. Sherlock,et al.  The prognostic role of a gene signature from tumorigenic breast-cancer cells. , 2007, The New England journal of medicine.

[12]  Takeharu Nagai,et al.  Shift anticipated in DNA microarray market , 2002, Nature Biotechnology.

[13]  S. Asano,et al.  Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector , 2003, Gene Therapy.

[14]  Michael Karin,et al.  NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.

[15]  H. Beug,et al.  Epithelial-mesenchymal transition: NF-kappaB takes center stage. , 2004, Cell cycle.

[16]  R. Beroukhim,et al.  Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.

[17]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Charlotte Kuperwasser,et al.  Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy , 2008, Breast Cancer Research.

[19]  Gema Moreno-Bueno,et al.  Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. , 2008, Cancer research.

[20]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[21]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  O. Er,et al.  Cancer Stem Cells in Solid Tumors , 2009, Oncology Research and Treatment.

[23]  R. Medzhitov,et al.  Toll-like receptors and cancer , 2009, Nature Reviews. Cancer.

[24]  B. Torbett,et al.  Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. , 1999, Science.

[25]  T. Shono,et al.  Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress , 1996, Molecular and cellular biology.

[26]  K. Umezawa.  Inhibition of tumor growth by NF‐κB inhibitors , 2006 .

[27]  H. Beug,et al.  Epithelial-Mesenchymal Transition: NF-κB Takes Center Stage , 2004 .